Loading the company…
Loading the company…
㈜유진메디케어
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Gyeonggi, founded in 2020. Industry: Medical & Precision Devices. Revenue for 2025 was ₩105.1bn. It has 148 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2021-03-22 · newest first
본 발명은, 유축기용 클립에 관한 발명으로서, 상방과 하방이 개방된 통 형상의 본체부와, 본체부를, 산모의 가슴에 부착시켜 모유를 유축하기 위해 사용되는 유축기에 결합시키기 위한 결합부와, 한 쌍의 집게편으로 구성되고, 본체부와 한 쌍의 집게편 사이에서 모유 저장 용기의 입구부를 협지하여, 모유 저장 용기가 상기 본체부에 유지하도록 하는 1조의 집게부를 구비하고, 1조의 집게부를 구성하는 한 쌍의 집게편이 서로 대향 배치되도록, 본체부의 외주 표면 상에 상기 집게편이 각각 힌지 결합되어 있는 것을 특징으로 한다. 본 발명에 의하면, 산모가 간이한 방법으로 유축기와 저장 용기를 결합시킴으로써, 유축기에 의해 유축되는 모유를 직접 별도의 저장 용기에 직접 옮겨 담을 수 있어, 사용 편의성을 높이는 것과 함께 모유의 유실을 최소화할 수 있다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 99.3 | 105.1 |
| Cost of sales | 78.0 | 81.8 |
| Gross profit (loss) | 21.3 | 23.3 |
| Selling, general and administrative expenses | 5.4 | 7.2 |
| Operating income (loss) | 15.9 | 16.1 |
| Non-operating income | 4.1 | 1.8 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.4 | 0.6 |
| Other | 3.7 | 1.2 |
| Non-operating expenses | 1.5 | 2.1 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 1.0 | 0.9 |
| Other | 0.6 | 1.2 |
| Profit (loss) before tax | 18.6 | 15.8 |
| Income tax expense | 3.5 | 3.4 |
| Net income (loss) | 15.1 | 12.4 |
Revenue ₩105.1bn, up 5.8% YoY.
Operating margin 15.3% (prior 16.1%).
Net income ₩12.4bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-05